Black-White Disparities in Asthma Hospitalizations and ED Visits Among Medicaid-Enrolled Children

Laura Barrie Smith1, Claire O'Brien1, Genevieve M Kenney1

  • 1Urban Institute, Washington, District of Columbia.

Hospital Pediatrics
|May 16, 2024
PubMed

Insights

Black children with asthma on Medicaid experience more than double the hospitalizations and emergency department visits compared to white children. Addressing disparities requires tackling poor care quality, discrimination, and environmental factors contributing to asthma triggers.

Area of Science:

  • Pediatric Health
  • Health Disparities Research
  • Public Health Policy

Background:

  • Asthma is a prevalent chronic condition in children, disproportionately affecting Black children.
  • Preventable hospitalizations and emergency department (ED) visits for childhood asthma are significant public health concerns.
  • Medicaid coverage for nearly half of children with asthma should facilitate care access, yet racial disparities persist.

Purpose of the Study:

  • To investigate racial disparities in asthma-related hospitalizations and ED visits among children enrolled in Medicaid.
  • To provide new evidence on the magnitude of these disparities using comprehensive claims data.

Main Methods:

  • Utilized the Transformed Medicaid Statistical Information System (T-MSIS) for comprehensive Medicaid claims data.
  • Analyzed data for 279,985 Medicaid-enrolled children diagnosed with asthma in 2019.
  • Estimated adjusted odds ratios for asthma hospitalizations and ED visits comparing non-Hispanic Black to non-Hispanic white children, controlling for demographic and plan-related factors.

Main Results:

  • In 2019, 1.2% of Black children with asthma had a hospitalization versus 0.5% of white children.
  • 8.0% of Black children experienced an ED visit compared to 3.4% of white children.
  • Adjusted analyses revealed Black children had over twice the odds of hospitalization (aOR 2.45) and ED visits (aOR 2.42) for asthma compared to white children.

Conclusions:

  • Significant racial disparities exist in asthma hospitalizations and ED visits among Medicaid-enrolled children.
  • Addressing these disparities necessitates interventions targeting healthcare quality, discriminatory practices, and socioeconomic factors.
  • Solutions must mitigate structural inequities that increase Black children's exposure to asthma triggers and healthcare access barriers.
Abstract

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.5K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
3.0K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
277
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K